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ABSTRACT PAGE

Therm oregulatory neurons in the preoptic area of the anterior
hypothalamus (POA) form synaptic networks, which affect responses
th a t regulate body tem perature. In order to characterize these
pathways of activation, projections to effector control areas, like the
dorsomedial hypothalamus (DMH) or raphe pallidus (RPa), require
labeling in live tissue slices. Traditional fluorescent dyes label axon
term inals near an injection site, and unfortunately, also th at of nearby
fibers of passage. Here, we describe a novel m ethodology for
retrograde labeling of neurons in vitro, while also allowing for fu rth e r
electrophysiological recording. To determ ine if POA neurons project to
either the DMH or RPa, we have used nanometer-sized, gold
nanoprobes, which provide fo r specific neuronal entry, via synapses in
close proxim ity to the injection site. Upon neuronal entry, these
nanoprobe complexes transport to the soma, where they are readily
visualized and quantified. We found that conjugation of these gold
nanoprobes with VGLUT-2 antibodies and polyethyleneimine (PEI)
facilitate neuronal entry among glutam atergic neurons, with high
levels of labeling efficacy with the POA. Probes with VGAT and PEI, on
the other hand, which are designed to preferentially enter GABAergic
neurons, show modest labeling of the POA. This novel method,
adapted from emerging cancer therapy technologies, is highly specific
fo r determ ining axon term inal projections within particular neuronal
populations, while simultaneously m aintaining neuronal viability fo r
targeted live cell electrophysiological recording.
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CHAPTER Is
Therm oregulation and the Hypothalamus

TH ER M O R EG U LA TIO N

Homeostasis involves the dynamic interaction between an
organism's internal processes and its external environm ent to maintain
physiological stability. One such homeostatic process is
therm oregulation. Among animals, there are therm oconform ers and
therm oregulators. A therm oconform er's body tem perature changes
based on external tem perature, whereas a therm oregulator maintains
its body tem perature within a particular range, in response to various
external, environm ental stim uli. Among therm oregulators, failure to
achieve therm oregulatory balance may result in physiological damage,
metabolic irregularities, or even death (Boulant, 2000).

In order to maximize heat loss in warm environm ents, mammals
typically employ a number of adaptations. These include physiological
strategies such as evaporative cooling (i.e. panting, perspiration),
highly vascularized extrem ities, and compartmentalized fat storage to
reduce insulation (e.g. camels). Other strategies involve behavioral
adaptations such as daytim e burrowing and increased nocturnal
activity. Conversely, mammals utilize a variety of strategies to retain
heat in cold environments. Physiologically, vascular countercurrent
exchange systems m itigate heat escaping through the extrem ities, by

transferring heat from outgoing arterial to incoming venuous blood.
Metabolic adaptation includes the ability to store metabolic energy in
the form of fat. Through thermogenesis, energy can be released
rapidly (e.g. shivering) or gradually (e.g. liver). Furthermore,
evolutionary pressures also select fo r advantageous anatomical
features, such as shortened extrem ities, or increased body size to
more easily facilitate a steady core body tem perature (Hammel and
Pierce, 1968).

Humans are therm oregulators and have thus been able to adapt
to a diverse set of climates. In cooler conditions, the human body
engages in thermogenesis (e.g. liver processes and muscle
contractions) to produce heat, and vasoconstriction to retain heat. In
warm er environm ents, humans engage in vasodilation and sweating to
transfer excess heat through evaporation. In addition to physiological
mechanisms, humans also employ other social (e.g. huddling), cultural
(e.g. clothing), and technological adaptations to produce or retain
heat.

Therm om eters provided the means to accurately measure
tem perature in animals. Because rates of heat loss and heat
production vary in different parts of the body, local tem perature

readings may differ considerably. Although circulating blood tends to
standardize body tem perature, the identification of body parts that
closely match those of the internal organs have proven useful in
ascertaining core tem perature. These body parts include the rectum,
uterus, bladder, m outh, ear, and groin (Hammel and Pierce, 1968).

Heat Loss

When environm ental tem perature is above core body
tem perature, humans lose heat through evaporation by secreting
sweat. Furthermore, dermal hairs lie flat to prevent air retention
between them , and thus com plem ent convective heat loss.
Vasodilation is another mechanism by which humans lose heat.
Relaxation of smooth muscle in arteriole walls increases arterial blood
flow. By redirecting blood to distal parts of the body, such as the skin,
heat is lost through radiation and convection. In contrast to humans,
only few other mammals lose heat prim arily through sweating (e.g.
horses). Rats, mice, cats, and dogs possess sweat glands exclusively
on th e ir foot pads. Instead, many mammals (e.g. dogs) pant to cool
th e ir bodies. Highly vascularized lungs, with a large surface area,
facilitate heat exchange between the air and th e ir bodies.
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Heat Retention/Production

In contrast to heat loss, humans apply the opposite mechanisms
to retain heat whenever environm ental tem perature dips below core
body tem perature. Sweat pathways are deactivated. Vasoconstriction
is achieved by constricting subdermal capillaries and thus, shunting
blood away from the skin and the body's periphery. In extrem ely cold
conditions, prolonged rerouting of blood away from the extrem ities
causes numbness and cellular damage (e.g. frostbite). To augment
heat retention, humans contract miniscule subdermal muscles (erector
pili) to erect dermal hair follicles. These erect hairs form an insulating
layer capable of trapping heat. Furthermore, humans and some
animals produce heat in an exotherm ic process called thermogenesis.
Effector signal from the hypothalamus reach peripheral muscles to
cause shivering. Humans engage in short-term shivering, where heat
is produced through high-intensity glucose metabolism in a relatively
short period of tim e. Other animals, such as bears, are capable of
long-term shivering, often for months, by gradually and steadily
metabolizing fa t stores.

Circadian Rhythm

Daily variations in body tem perature have been observed in
mammals, particularly humans and rats. The daily peak of body
tem perature rhythm in rats was found to consistently follow the daily
peak of heat production rhythm and to precede the daily peak of heat
loss rhythm . Furthermore, the daily rhythm of heat balance is 180
degrees out of phase with the rhythm of body tem perature. Animals
with lesions in the dorsomedial nucleus of the hypothalamus (DMH)
maintained a normal circadian variation, though body tem perature
remained 0.5°C lower. Rat studies have shown th a t the circadian
rhythm may be inverted by restricting food access to daylight hours.
When only perm itted to eat during the latter half of the light period,
these animals awaken and increase body tem perature a few hours
before food adm inistration. Lesion studies have determined th at the
ability to alter rhythm s in body tem perature, as well as the wake-sleep
cycle, feeding, activity, and corticosteroid rhythm s, correlate with DMH
activity (Refinetti, 2003).

Sleep

Mammals sleep to conserve energy, during which decreased body and
brain tem peratures are observed. Small mammals tend to sleep the
most, since they also have higher energy demands for
therm oregulation and locomotion, while possessing relatively lower
energy reserves. Disruption of normal sleep cycles has been associated
w ith therm oregulatory irregularities. For example, chronically sleepdeprived rats show increased preference fo r cooler am bient
tem peratures (~10°C ), which suggests sleep has cooling function.
Conversely, rats sleep deprived for two weeks show a significant
decrease in body tem perature despite a doubling in metabolic rate,
suggesting sleep's role in heat retention. In humans, increased
hypothalam ic tem perature induces sleep, and body heating prior to
sleep increases subsequent slow wave sleep (Saper et al., 2005).

HYPOTHALAMUS

Found in all mammalian brains, the hypothalamus is located ventral to
the thalamus, where it coordinates certain metabolic processes and
various autonomic nervous system activities, as well as, synthesizes
and secretes particular hormones. Stim ulation and ablation studies
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have determined that the preoptic anterior part of the hypothalamus
(POA) is crucial fo r therm oregulation (Hammel et al., 1963).
Approxim ately 40% of POA neurons are tem perature-sensitive, while
the rest are insensitive. Local warming of POA neurons evoked heat
loss responses, where as local cooling induced heat production. This
observation led to the idea tha t the POA as an area responsible for
therm oregulatory control, i.e. the body's "central therm ostat"
(Boulant, 2000).

Hammers Model

In the 1960s, the six-neuron Hammers model, named after its
developer, proposed th a t set-point tem perature was determined by
the integration of afferent signals with neuronal interactions within
POA (Fig. 1). The model proposed th a t warm -sensitive neurons
positively synapse on warm effector
neurons, whereas tem perature-insensitive inhibit them . The
tem perature where excitation equals inhibition determines is the setpoint. Above the set-point tem perature, warm effector neurons receive
more stim ulation than inhibition, thus leading to heat loss behavior.
Conversely, tem perature-insensitive neurons positively synapse on
cold effector neurons, whereas warm -sensitive inhibit them. Below the

set-point tem perature, cold effector neurons receive more stim ulation
than inhibition, thus initiating heat retention/production behavior
(Hammel et al., 1963).

Neuroanatomical Correlates

Observed heat loss behaviors include vasodilation, panting, and
sweating, while heat production behaviors involve vasoconstriction,
shivering, breakdown of brown adipose tissue, and huddling. Further
studies have determined th a t heat loss and production are triggered
by the actual am bient tem perature, and not by the rate of change in
tem perature, since no burst of neuronal firing rates were detected
during rapid tem perature change. Hypothalamic tem perature does not
vary considerably (range: ± 1°C) even when am bient tem perature is
changed drastically. However, drops in hypothalamic tem perature
below this range often induce a coma and other neuroprotective
mechanisms (Hammel et al., 1963).

10

Figure 1. H a m m e rs Model. A modified six-neuron model explaining
the hypothalamic determ ination of set-point tem perature. Key: FR,
firing rate; W, warm -sensitive neuron; I, tem perature-insensitive
neuron; w, heat loss effector neuron having synaptically derived-warm
sensitivity; c, heat production effector neuron having synapticallyderived cold sensitivity; SP, dorsal horn spinal neuron; OC, optic
chiasm; MB, m am m illary body. Adapted with permission from Boulant,
J. A. (2006) Neuronal basis of Hammers model fo r set-point
therm oregulation.
Cutaneous
Afferent
Pathway

SP]

FR

PR

Heat
Loss
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Changes in the activity of neurons in the POA have been correlated
with initiation of therm oregulatory mechanisms. Nearby areas, such as
the DMH, may include therm oeffector neuron. Electrical stim ulation of
the DMH induced an increase in heat production behavior. Retrograde
labeling show dye beads transported to the lateral hypothalamus (LH),
POA, ventrom edial preoptic (VMPO), and paraventricular area (PVN). It
is thought th a t the POA may have direct control of the DMH
(Nakamura et al., 2005).

Neuronal Therm osensitivity

Various in vivo and in vitro electrophysiology studies have identified
four types of therm oregulatory neurons: warm -sensitive, coldsensitive, tem perature-insensitive, and silent. Among these types, the
vast m ajority of the POA neuronal population comprise of warm sensitive (~ 3 0 % ) and tem perature-insensitive (~ 6 0 % ) neurons. One
main difference between these two types is th at warm -sensitive
neurons not only inherently respond to local therm al input, but also to
hypothalamic, skin, and/or spinal tem perature. Conversely,
tem perature-insensitive neurons do not exhibit tem perature-related
changes in activity (Boulant et al., 1997).

Thermal Classification

Historically, tem perature sensitivity has been ascertained in one of two
ways: either through the determ ination of a Qio therm al coefficient, or
through calculation of the neuronal firing rate regression line slope.
The slope reflects the number of action potentials as a function of
hypothalam ic tem perature (Boulant et al., 1997).

Using the la tte r criteria, tem perature-sensitive neurons can be divided
into two subgroups: warm - (35% POA) and cold-sensitive (5% ).
W arm-sensitive neurons fire at > 0.8 im pulses/sec/°C, when the POA
tem perature is changed by ± 2-3°C (Boulant et al., 1997). Warmsensitive neurons respond to both direct changes in hypothalamic
tem perature and peripheral therm al stim ulation. They also have a
distinct lateral/m edial orientation in dendritic m orphology, which is
consistent with th e ir roles as integrators of therm al inform ation (Griffin
et al., 2001). Cold-sensitive neurons, on the other hand, fire at < -0.6
im pulses/sec/°C when POA tem perature is changed by ± 2-3°C. Unlike
w arm -sensitivity, cold-sensitivity is not an inherent property, and may
be a result of synaptic input from nearby warm -sensitive and
insensitive neurons (Boulant et al., 1997).

In contrast, tem perature-insensitive neurons show little change in
firing rate, when tem perature deviates from the normal physiological
condition (~37°C ). Tem perature-insensitive neurons fire at < 0.79
im pulses/sec/°C and > -0.6 im pulses/sec/°C when the POA
tem perature is changed by ± 2-3°C. Essentially, this range is between
the firing rates of warm - and cold-sensitive neurons (Boulant et al.,
1997). Unlike th e ir w arm -sensitive counterparts, tem peratureinsensitive neurons extend th e ir dendrites in rostral/caudal directions,
consistent with th e ir roles as indicators of baseline of hypothalamic
activity (Griffin et al., 2001).

The characterization of physical differences between tem peraturesensitive and insensitive neurons is an active area of research. These
differences in firing rates may be determined by various ionic
conductances, such as tandem -pore K+ leak channels (TASK, TREK,
and TRAAK), transient K+ A-current channels, hyperpolarizationactivated cyclic nucleotide-gated channels (HCNs), and vanilloid
transient receptor potential (TRP) channels. The proportion of these
channels within the hypothalamus may explain the difference among
w arm -, cold-sensitive, and tem perature-insensitive neurons
(Wechselberger et al., 2006). I t has been observed tha t increased
tem perature positively correlated with both firing rate

therm osensitivity and A-current inactivation, resulting in a higher
probability of reaching firing threshold (Griffin et al., 1996).

MEDICAL IM P L IC A T IO N S

Fever

Several studies estim ate th at the average core tem perature for
healthy adults is approxim ately 98.2 °F or 36.8 °C. When presented
with an immunological challenge, the human body undergoes a
cascade of factors th a t signal the brain. The resulting rise in body
tem perature of 1-4°C is defined as a fever. Metabolically, specific
cytokines cause production of prostaglandin (PGE2) in the brain, which
in turn affects neuronal activity in the ventram edial preoptic (VMPO;
Blatteis and Sehic, 1998). Introduction of PGE2 to this region or
stim ulation of afferent pathways causes significant rise in body
tem perature (> 1° C). According to Hammers model, an increase in
the firing rate of tem perature-insensitive neurons and/or a decrease in
the firing rate of warm -sensitive neurons result in a new, higher setpoint. The presence of PGE2 causes warm -sensitive neurons to
decrease th e ir firing rate and tem perature-insensitive neurons to be
unaffected or increase th e ir firing rate (Ranels and Griffin, 2003).
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Thermal Dvsreaulation

Because of the hypothalam us' importance in therm oregulation,
injuries, tum ors, genetic abnorm alities, and its exposure to pyrogenic
and other exogenous compounds may cause therm al dysregulation.
Because the POA can be influenced by factors besides tem perature,
(e.g. glucose levels, testosterone, estrogen, osmotic balance, etc.),
dysfunctions in maintenance of these factors may be comorbid with
therm al dysregulation. Furtherm ore, metabolic and physiologic
conditions, such as hormonal imbalance and poor blood circulation,
may contribute to abnormal body tem perature.

CONCLUSION

To summarize, therm oregulation is a dynamic, homeostatic interaction
between an organism's internal processes and its therm al
environm ent. To maintain physiological stability, many organisms
employ processes such as heat loss, retention, and production. These
therm oregulatory mechanisms influence other aspects of life, such as
sleep and circadian rhythm s. Among mammals, the hypothalamus
(located deep within the brain) coordinates certain metabolic
processes, regulates various autonomic nervous system activities, and

synthesizes/secretes particular hormones critical to therm oregulation.
Through therm al dysregulation and protective mechanisms like fever,
we are reminded of therm oregulation's importance in maintaining life.

Hypothesis:
Synaptic entry of novel nanoprobes within the DMH will result in
somatic labeling in the POA, confirming connectivity. Probe
conjugation, with either VGLUT-2 or VGAT antibodies, will facilitate
preferential entry into either glutam atergic or GABAergic synapses.

SPECIFIC A IM :
Although recent evidence has suggested tha t POA neurons project to
the DMH, direct dem onstration of these connections and the distinct
phenotypic populations responsible for the activation of
therm oregulatory responses remains to be elucidated.
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CHAPTER I I :

In Vitro Application of Gold Nanoprobes in Live Neurons for
Phenotypical Classification, Connectivity Assessment, and
Electrophysiological Recording

1. IN T R O D U C T IO N

Therm oregulatory neurons in the preoptic area of the anterior
hypothalamus (POA) form synaptic networks, which affect responses
th a t regulate body tem perature around a set-point (Boulant, 1997;
Hammel, 1965). Changes in this area's neuronal activity have been
correlated with the initiation of therm oregulatory mechanisms (Griffin
et al., 1996; Im bery et al., 2008; Saper and Breder, 1994). Recent
studies also suggest th a t certain therm oregulatory phenomena, such
as hypertherm ia, can be elicited by activation of neurons in the
dorsomedial hypothalamus (DMH) and the nucleus raphe pallidus
(RPa), which receive direct input from neurons in the POA (Nakamura
and Morrison, 2008; Nakamura et al., 2009). Therefore, in order to
produce these distinct changes in therm oregulatory control, POA
neurons may have direct axonal connections to the DMH or RPa.
Although recent evidence has suggested th a t POA neurons project to
these areas (Nakamura et al., 2009), direct demonstration of these
connections and the distinct phenotypic populations responsible for the
activation of therm oregulatory responses remains to be elucidated.

In order to determ ine the therm oregulatory role of POA neurons that
project to the DMH or the RPa, th e ir phenotypes and connectivity must
be characterized. Past studies have attem pted to phenotype these
neurons through th e ir synaptic projections. For example, certain
techniques, such as glutam ate decarboxylase staining, resulted in
localization of not only the synapses of interest, but also nearby axonal
fibers (Schaffer and Griffin, 2006). While the m ajority of POA neurons
are thought to be inhibitory (Nakamura and Morrison, 2008;
Nakamura et al., 2009) and therefore GABAergic, the literature
describes the glutam atergic system in more detail due to its
abundance in the mammalian brain (Meldrum, 2000). This made the
glutam atergic system more accessible for initial investigation. Once
proof of principle was established, investigation of the GABAergic
system subsequently followed.

Recent developments, in the field of bionanotechnology have yielded
new approaches to supplement m olecular studies at the subcellular
level (Bergen et al., 2008; Grimm et al., 2004; Kukowska-Latallo et
al., 2005; Merrifield et al., 2005). For example, metallic nanoparticles,
through th e ir biocom patibility and low toxicity, are gradually
expanding drug delivery and cancer treatm ent options (KukowskaLatallo et al., 2005; Sperling et al., 2008; Vasey et al., 1999). The
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potential uses fo r nanoparticles, however, are not confined to these
applications. In addition to therapeutic applications as vehicles,
nanoparticles may expand bioimaging techniques as contrast agents,
by functionally assessing and localizing specific molecular signatures or
physiological systems (Portney and Ozkan, 2006; Shamsaie et al.,
2007; Thurn, 2007). Furthermore, because of the nanoparticles'
m etallic properties, the photoelectric effect neutralizes photobleaching
concerns associated with conventional fluorescent dyes (Thurn, 2007).

Cellular m etallic nanoparticle studies have recently come into
existence, and literature involving neuronal applications are still
evolving (Olivier, 2005). Here, we report an adaptation of this
technology as a potential tagging system fo r neuronal pathway
identification in vitro. Whereas previous studies involved gold
nanoparticle vehicles delivering genetic or drug payloads to the
nucleus of a cell (Olivier, 2005), we have adapted the original intent of
these nanoparticles, whereby the payload (subsequently referred to as
'conjugates') facilitate delivery of the vehicle (i.e. gold nanoparticle) to
the neuronal soma. This has allowed us to characterize both
glutam atergic and GABAergic neurons in a tissue slice preparation,
which synapse in the DMH and originate from within the POA. Since
the nanoparticles used are non-lipid soluble, and are specifically

conjugated to enter and escape the synaptic vesicular machinery,
these nanoparticles allow us to probe fo r a neuron's somatic origin, via
the synapse, by retrograde diffusion or facilitated transport.

Since thin neuronal tissue slices remain viable in vitro fo r up to 12
hours under proper conditions, an appropriate retrograde labeling
technique must work within this tim e period to allow fo r the targeted
electrophysiological recording of these neurons in the POA. Other highcontrast, "gold standard" methods, such as Fluorogold (LlewellynSmith et al., 1990; Moore et al., 1995; Tong et al., 1999), cholera
toxin B-gold, and immunogold silver staining exist. However, only our
adapted gold nanoprobe (AuNP) technique sim ultaneously offers the
appropriate tim e course, specificity, and low biotoxicity (Allen et al.,
1988; Chan et al., 1990; Cowan et al., 1994; G illitzer et al., 1990;
Naumann et al., 2000) required to leave neurons of interest suitably
intact fo r live-cell recording. Finally, techniques lacking actual m etallic
components, like Fluorogold, exhibit lim itations found in fluorescent
dyes, such as potential labeling of nearby fibers of passage (Chen and
Aston-Jones, 1995; Dado et al., 1990) and photobleaching.

2. EXP E R IM E N TA L PROCEDURES

2.1 Hypothalamic Tissue from Rat Brain

Extraction procedures of hypothalam ic tissue have been previously
described in detail (Griffin et al., 1996; Griffin et al., 2001; Im bery et
al., 2008; Olivier, 2005). Briefly, brain tissue sections containing the
DMH and POA were prepared from male Sprague-Dawley rats (Harlan;
100-150 g), th a t were housed under standard conditions and provided
food and w ater ad lib. Before each session, a rat was anesthetized
using isoflurane and prom ptly decapitated, following procedures
approved by the Animal Care and Use Committee of the College of
William and Mary. A fter dissection of the brain, a tissue block
containing the hypothalamus was mounted on a vibratom e and bathed
in artificial cerebral spinal fluid (aCSF). Sagittal plane, 400 pm -thick
tissue sections were produced and then placed in a submersion
recording chamber.

2.2 Tissue Perfusion and Probe Injection

Tissue sections were continually perfused with normal aCSF, which
consisted of (in mM): 124 NaCI, 26 NaHC0 3 / 10 glucose, 5 KCI, 2.4

CaCh, 1.3 MgS04/ and 1.24 KH2 PO4 . A fter gentle aeration (95% 02,
5% CO2 ), the aCSF (300 mOsM; pH 7.5) was allowed to gravity flow at
1-2 m l/m in into the recording chamber (volume = 2 ml).

Approxim ately 1-5 pL of probe solution (AuNPs in bovine serum
albumin suspension) were backfilled into glass microelectrodes pulled
to a tip diam eter of ~ 2-5 pm. The solution was pressure-injected into
the tissue area of interest, using a nitrogen puffer system (Fig. 2).
Successful injection sites aimed at the DMH, regardless of probe type,
were designated as 'ta rg e t' tissue (n = 57), while non-DMH were
'co n tro l' (n = 7). Tissue classified as non-DMH included injection sites
in the anterior hypothalamic area (AHA) or the ventromedial
hypothalamus (VMH). Probes were allowed to diffuse through the
tissue fo r an average of 5.9 ± 0.1 h at a mean tem perature of 35.5 ±
0.18°C. A thermocouple was placed adjacent to the tissue slices to
constantly m onitor the tem perature.

Upon tissue placement into the chamber, a small concentration of gold
nanoprobes was pressure-injected into the DMH (Fig. 3). These AuNPs
are spherical, colloidal nanoparticles composed of a dielectric silica
core and an ultra-thin m etallic (gold) coating, providing them with a
strong reflectivity (peak wavelength: glutam atergic = 524 nm,
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GABAergic = 510 nm ), and an extrem ely low biotoxicity. For our
purposes, the glutam atergic AuNPs were conjugated with a polyclonal
antibody for the rat vesicular glutam ate transporter type-2 (VGLUT-2;
Millipore) and polyethyleneimine (PEI; Nanopartz, Inc.).
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F ig u re 2. A n a to m ic a l and d is ta n c e o rie n ta tio n in in je c te d tis s u e .
Tissue-level im age (4 x ) o f in je ctio n site in the DMH, labeled soma in
th e AHA/POA, and o th e r anatom ical landm arks.
DM H:
Fx:
AC:
AHA:
A , B:

dorsom edial h yp o th alam u s
fo rn ix
a n te rio r com m issure
a n te rio r h yp o th alam us, which contains the POA
arrow s p o inting to labeled soma

200 urn

29

F ig u re 3. S c h e m a tic D ia g ra m o f P ro b e A o r Z's M e ch an is m .
Probe in je ctio n in th e DMH allow s ve sicular uptake at the axon
te rm in a l, (a) Probe conjugates, such as VGLUT-2 or VGAT antibodies
(c u rv y line) and PEI m olecules (Y -shape), are surface -con ju g ated on
gold nanoshells (circle ), (b) These conjugates fa cilita te m em brane
protein a tta c h m e n t during vesicular fo rm a tio n and, late r, (c)
endosom al escape fro m the ve sicu lar lum en into the cytosol.
In tra c e llu la r diffusion and possible retro g ra d e axonal tra n s p o rt
m achinery fa c ilita tio n re sult in nanoaggregate deposition in the
neuronal som a.

This fully-conjugated nanoprobe complex, consisting of both V-GLUT-2
antibodies and PEI polymers attached onto a gold nanoshell (diam eter
= 5 nm), was designated as Probe A. GABAergic probe complexes
were sim ilarly constructed, only th at the VGLUT-2 antibodies were
replaced with polyclonal antibodies for the rat vesicular GABA
transporter (VGAT; Millipore; peak wavelength = 510 nm). The VGAT
and PEI double-conjugated probe was designated Probe Z. From this
point onwards, adm inistration methodology and experimental
conditions for the VGAT probes were sim ilar to the VGLUT-2 probes.

A fter injection into the tissue slice, specific antibody binding of Probe A
to nearby VGLUT-2s (which are exposed to the term inal surface during
vesicle form ation) facilitates AuNP uptake exclusively into synaptic
vesicles at axon term inals (Jung et al., 2006). Once inside a newlyformed vesicle, "endosomal escape" occurs when the attached,
cationic PEI conjugates sequester surrounding protons. To maintain
chemiosmotic balance, vesicular ATPases continue to pump protons
into the vesicular space. To maintain electrochemical balance, chloride
ions follow into the vesicle, through the ir own channels. Increasing
concentrations of both ions attract water molecules into the vesicular
lumen, initiating a progressive "proton sponge effect" (Bergen et al.,
2008; Guerra-Crespo et al., 2003; Suk et al., 2007; Wu et al., 2004).

Upon hydrosaturation, the vesicles lyse and a significant number of
AuNPs diffuse into the cytosol. Over the next several hours, while the
tissue slice equifibrates to the chamber environm ent, some AuNPs will
retrogradely transport from the synaptic term inal region to the
neuronal soma (Bergen et al., 2008; Suk et al., 2007).

2.3 Histology

Upon removal from the recording chamber, the tissue sections were
allowed to soak in 30% paraformaldehyde/sucrose solution at 12°C for
a m inimum of 3 h. Tissue was frozen and sliced into 50 pm thick
sections using a microtome (Leica SM-2000R). A fter suspension in
phosphate-buffered saline, the tissue sections were mounted on slides
and were given 12 h to dry at room tem perature before beginning the
staining process. Slides were first placed in a 50/50 chloroform/alcohol
solution for 3 h at room tem perature. Afterwards, they were carried
through a series of rehydration steps, for five minutes each in 300 ml_
of, successively, 95.5% reagent alcohol, 70% reagent alcohol, and
distilled water, followed by a 5 min submersion in phosphate buffer
monobasic solution and 4 min in giemsa stain. Excess stain was then
removed via 2 min agitation in 95.5% reagent alcohol before the slides

were placed in 300 mL of xylene (Sigma, 98 .5 + % ) for 12 h. Slides
were coverslipped and allowed 12 h to set before microscopy.
2.4 Probe Visualization and Quantification

The location and confirm ation of each injection site were noted on a
section diagram adapted from a rat brain atlas (Pellegrino et al.,
1979). Quantification of the probes involved tallies of labeled neurons
and their location. Labeled neurons were readily identified by the
presence of AuNPs in th e ir giemsa-stained somas, which can be
visualized under normal bright field illum ination, and then confirmed
through th e ir reflective properties under dark field illum ination. To
reduce bias, undergraduate counters were blinded to the tissue
sample's probe treatm ent. Microscopy images were obtained using an
Olympus CCD camera (DP11) at 4x, lOx, and 40x magnification. Fuilimage brightness and contrast were non-destructively adjusted using
Adobe Photoshop.

2.5 Control Probe Configurations

To determ ine the differential contribution of the complex's
components, isolation of individual component effects was required. To
accomplish this, progressively simpler, control probes were designed

by removing individual modifications. A fter testing the performance of
the complete probe (Probe A; AuNP + VGLUT2 antibody + PEI), we
studied the properties of Probe B (AuNP + VGLUT2 antibody only),
Probe C (AuNP + PEI only), and finally Probe D (AuNP shell only,
diam eter = 5 nm). All probes were synthesized by Nanopartz, Inc.

2.6 Colchicine Treatm ent

To determ ine whether passive diffusion or facilitated transport through
the axonal machinery is the prim ary mode by which the probes reach
the soma, 100 nM of the m icrotubule form ation inhibitor colchicine
(Sigm a-Aldrich; dissolved in distilled water) was co-administered with
Probe A (n = 8). Both Probe A and colchicine solution were backfilled
onto the same electrode prior to pressure injection.

2.7 Statistical Analysis

Mann-Whitney U-tests (nonparam etric data) or Student's T-tests
(param etric data) were conducted when comparing two treatm ent
groups, whereas a Kruskal-Wallis test was utilized for three or more.
Chi-square tests were used to compare between probe efficacy results.
To determ ine which factors influence the quantity of labeled neurons

within the POA, a principal components analysis (PCA) was used to
develop a m ultiple regression model. Robust regression confidence
intervals and standard errors were generated using a replacementand-resampling bootstrap method (Efron, 1977; Efron, 1994). These
estimates were bias-corrected and validated using a separate jackknife
procedure (Efron, 1977). Unless otherwise noted, P-values < 0.05
were stated as statistically significant. Statistical analyses were
performed using Stata 10 (StataCorp. LP).

3. RESULTS

Trials assessing the efficacy of Probe A yielded results dependent on
initial probe injection location. Significant differences in somatic
labeling were observed between tissues injected in the DMH as
compared to non-DMH tissues (Fig. 4), whereby probe injection into
the DMH resulted in significantly higher POA somatic labeling. DMHinjected samples also displayed a relatively higher variance in POA
labeling compared to non-DMH, with at least one sample exhibiting
over 60 labeled soma. Discrete reflecting units within clearly-m arked
somas were observed (Fig. 5 a,b,c). Reflectance observed does not
represent individual nanoprobe complexes, since individually, these
particles have insufficient surface area to reflect the necessary am ount
of light perceivable to the human eye. Instead, what we are likely
seeing are collections of several probes that can be best described as
nanoaggregates (Kneipp et al., 2006). An adjusted density map was
constructed to visualize Probe A's spatial distribution in DMH-injected
tissue (n = 20). In tissue slices with confirmed injection sites in the
DMH, the m ajority of labeled cells were located near the POA. Not
surprisingly, the highest densities (excluding areas im m ediately
surrounding the injection site) were observed in the rostral sections of

Figure 4. Efficacy of Probe A of DMH vs. non-DM H Tissue. The
number of labeled POA neurons is significantly higher, if the injection
site is located in the DMH.
Probe A Efficacy on Target vs. Control Tissue
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Figure 5 a, b, and c. Microscope im ages o f labeled neurons.
Images (40x) in visible light (a), dark field (b), and superimposed
composite (c) show distinct probe nanoaggregates within giemsastained POA soma. Arrows indicate labeled soma.
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A L

the POA -- the area closest to the DMH (Fig. 6). In contrast, control
tissue with injection sites to the m am m illary peduncle or AHA, showed
significantly lower POA somatic labeling. Outside the POA, probes were
relatively scattered. Higher probe accumulations reported in soma
closer to the injection site (i.e. labeled, non-POA neurons) may reflect
shorter traveling tim es due to sm aller distances. Longer perfusion
times may result in increased labeling within the POA proper, though
this speculation may require fu rth e r testing. Another possibility is that
Probe A is term inally labeling somas in the area rostral to the POA. If
th a t is the case, this may provide evidence th at this area may also
provide effector signals to the DMH. Due to tim e lim itations, we were
not able to investigate this possibility further. Future experiments may
be warranted to provide answers.

A linear, m ultiple regression model was developed to determ ine the
incremental effect of probe type, location of injection site, diffusion
tim e, and perfusion tem perature respectively, on the number of POA
neurons labeled. All explanatory variables were assessed for
collinearity, and ail showed sufficient independence. The regression
model significantly explained approxim ately 50% of the POA labeling
variation.

Bootstrapped linear regression models (n = 45, iterations = 10,000)
indicate that, overall POA labeling was significantly affected by probe
configuration and injection site (Table 1). Injection in the DMH yielded,
on average, significantly more POA labeling, after controlling fo r probe
type and other factors. Although diffusion tim e differences did not
show significance at the

a

< 0.05 level (m ost tissue slices were

perfused for approxim ately 6 hours with minimal variation), future
investigation and manipulation of this variable may be inform ative.
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Figure 6. Probe A spatial distribution. Normalized spatial
distribution of Probe A in DMH-injected tissue (n = 20) show higher
labeling density in the anterior POA and areas im mediately rostral to
the POA. Grid: The origin represents the DMH injection site. Higher
axis numbers indicate a more dorsal direction, while latter axis letters
indicate a more caudal direction. Legend: Number of labeled neurons
observed averaged over 20 slices.
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Table 1. Labeling Efficacy by Probe C onfiguration. Estimated
incremental contributions of each conjugate type and injection site to
overall labeled POA neurons are reported as beta coefficients and 95%
confidence intervals in the regression results.

N eith er
PEI only
VGLUT-2 only
Both

0
-6
2.3
11.6

5.4
4.9
5.1
5.4

Tissue type
Tim e (m in )
Tem p (°C )

11.7
-0.2
0.7

3.4
0.1
1.4

N
Replications
W ald chi-square
P-value
R-squared
Adj. R-squared

45
10000
31
0.0001
0.56
0.49

1
0.21
0.65
0.03

lower
-10.5
-15.6
-7.6
1

upper
10.5
3.5
12.3
22.3

0.001
0.07
0.65

5
-0.3
-2.1

18.5
0
3.4

The regression model described above (Table 1) also estimated the
incremental effect of individual conjugates on POA labeling efficacy,
where deconjugated probe configurations exhibited decreased overall
labeling efficiency (Fig. 7). When compared to baseline performance of
the "naked" 5 nm probe, the average increase/decrease in POA
neurons labeled were calculated by conjugate type, statistically
controlling for other factors. While adding either VGLUT-2 or PEI
individually may affect the efficacy of the probe, only the attachm ent
and interaction of both conjugates significantly improved POA labeling
over baseline (Table 1). I t was also noted that, in tissues treated with
control probes (especially unconjugated ones), somatic labeling was
generally more sporadic and less specific to any particular region of
the tissue. Because unconjugated, gold nanoprobes (like Probe D) are,
by design, biocompatible and inert, they are unlikely to initiate the
cell's immunological response and thus, be subject to degradation.
This property, when coupled with their miniscule size, makes "naked"
nanoprobes more likely to pass through the synaptic machinery, than
th e ir larger, conjugated counterparts (Verma et al., 2008). To
determ ine the effect of nanoprobe size, we enlarged the "naked" shells
tenfold and compared the performance of these extra-large probes
(Probe DX, diam eter ~ 47 nm; peak reflectance = 530 nm; Nanopartz,
Inc.) with their 5 nm counterparts. Fifty nanometers was chosen,
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Figure 7. Labeling Efficacy By Probe Type. The median number of
labeled POA neurons is significantly higher, when both VGLUT-2 and
PEI conjugates are present, with Probe A reporting a bootstrapped
population median estimate (iterations = 10,000) between 18-30
labeled neurons per 50-nm slice.
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Probe C onfigurations
A
B
C
D
DX

AuNP
AuNP
AuNP
AuNP
AuNP

+ VGLUT-2 + PEI
+ VGLUT-2
+ PEI
(~ 5 nm)
(~50 nm)

D (n = 10)

DX (n = 4)

because it is at the uppermost lim its of synaptic vesicle diameters;
most synaptic vesicles do not grow to be nearly this size (Harris and
Sultan, 1995). Chi-square comparisons between Probe D and DX
yielded a significant difference (Table 2) where Probe DX showed
lesser POA labeling efficacy. Probe DX performed even less efficiently
than all its 5-nm , deconjugated/unconjugated counterparts, registering
a sim ilar POA labeling efficacy to non-DMH Probe A samples. Besides
initial injection site and conjugate type, size may be another m ajor
factor affecting probe uptake (Chithrani et al., 2006). Differences
between Probe D and DX's spatial distribution were not apparent in the
anatomical position data.

Subsequent trials assessing the efficacy of the GABAergic probes
(Probe Z; n = 23; Fig. 8a) yielded significantly lower POA labeling
when compared to fully-conjugated glutam atergic probes (p < .001),
despite statistically sim ilar perfusion tem perature, diffusion tim e, and
initial injection volume. Spatial distribution patterns are sim ilar to that
of Probe A, where the densest labeling occurs in the anterior POA. It is
dissim ilar to Probe A, however, in tha t the lower overall labeling is
reflected by lighter density shades (Fig. 8b). Potential explanations for
the labeling disparity between the glutam atergic and GABAergic probes
are explored in the Discussion section.

46

Table 2. Chi-square results by probe configuration or injection
site. Overall, comparisons between probe configurations, based on
injection site, conjugate type, and probe size, indicate significant
efficacy differences.

A (nonDMH)
A (DMH)
B
C

15.03

DX
5.68

14.57
6.58

11.8

3.71
0.29
5.14

D

Bold values are significant at the .05 level.
Bold and italicized values are significant at the .01 level or less.
Probe C onfigurations
A
B
C
D
DX

AuNP + VGLUT-2 + PEI
AuNP + VGLUT-2
AuNP + PEI
AuNP (~ 5 nm)
A uN P (~ 50 nm)
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Figure 8, a and b. Labeling Efficacy and Spatial D istribution of
Probe Z. (a.) Probe Z labels POA neurons at a significantly lower
efficacy rate than Probe A (p < .001).
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(b .) Spatial distribution of Probe Z in ta rg e t tissue. Grid: The
origin represents the DMH injection site. Higher axis numbers indicate
a more dorsal direction, while lower axis letters indicate a more caudal
direction. Oval denotes POA area. Each grid cell is approxim ately 100
microns long. Key: Number of labeled neurons observed averaged
over 23 slices.
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To determine whether passive diffusion or facilitated axonal transport
contributes prim arily to somatic probe deposition, control tissues were
treated with colchicine. Colchicine inhibits microtubule form ation, and
consequently, shuts down axoplasmic transport. POA labeling is
significantly (p < .01) and substantially decreased upon colchicine
adm inistration (Fig. 9a), when compared to the non-colchicine
treatm ent. Spatial distribution analysis also confirms th at in colchicinetreated tissue, probes visualized outside the injection site tend to
remain proximal to th e ir synaptic entry points (Fig. 9b). From this we
conclude, th a t nanoprobe deposition in the soma is substantially
facilitated by the axonal transport machinery. The precise mechanism,
by which these probes "hitch a ride" to the soma, remains unknown
and may warrant fu rth e r study.
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Figure 9, a and b. Effect of Colchicine on POA Labeling and
Spatial D istribution, (a.) Simultaneous adm inistration of 100 nM
colchicine and Probe A significantly curtails POA labeling (p = .00 7),
suggesting facilitated axonal transport of nanoprobes.

Effect of Colchicine on POA Labeling Efficacy
00

“

< O

O LO

O-

c

A + 100 nM colchicine (n=8)

Treatment Type

B oxolot N o tation
m iddle bar:
shaded rectang le:
w hiskers:
dot:

median
interquartile range
upper/low er adjacent values
outlier

Probe Configuration
A

AuNP + VGLUT-2 + PEI

51

(b.) Spatial distribution of visualized probes in tissue treated with 100
nM colchicine. Grid: The origin represents the DMH injection site.
Higher axis numbers indicate a more dorsal direction, while lower axis
letters indicate a more caudal direction. Oval denotes POA area. Each
grid cell is approxim ately 100 microns long. Key: Number of labeled
neurons observed averaged over 8 slices.
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4 . D IS C U S S IO N

The mechanisms, by which the nervous system maintains or adjusts
body tem perature in response to therm al stressors, remain a
fundam ental area of study in physiology. Recent studies suggest that
responses, such as hypertherm ia, can be elicited by activation of
neurons in the DMH and RPa, which receive direct input from
therm ally-responsive neurons in the POA. Therefore, in order to
produce distinct changes in therm oregulatory control, these POA
neurons may have direct axonal connections to the DMH or RPa.
Phenotypical and connectivity assessments of neuronal populations
w ithin these areas could provide insight to their functional physiology.

Since VGLUT expression acts as a specific biom arker of a neuron's
glutam atergic phenotype (Santos et al., 2009), it is a sufficient
indicator of the glutam atergic machinery's presence within the
term inal. Of the three known neuronal VGLUT isoforms, hypothalamic
synapses predom inantly express VGLUT-2 (Varoqui et al., 2002).
Therefore, it is reasonable to conclude that probes with the VGLUT-2
antibody are preferentially binding to and being endocytosed in
glutam atergic axon term inals. By observing and quantifying neurons
labeled with Probe A, we were able to simultaneously ascertain a likely

glutam atergic phenotype, while confirming connections between the
DMH and the POA.
Although a median of approxim ately 20+ labeled neurons (out of a
population of thousands within the POA) may seem small, this number
only represents labeling from intact neurons within a single 400 pm
section, during a tim e course of only a few hours. Furthermore, when
considering the num ber of oblique, axonal fibers severed during the
slicing process, labeling of 60 or more neurons (like the outlier in Fig.
4) is still possible.

To understand the incremental contribution of the probe's constituent
parts, we need to elaborate on the mechanisms by which they affect
efficacy rates. Terminal uptake and endosomal escape can be classified
in two ways: facilitated and passive. During vesicular uptake, probes
with the VGLUT-2 antibodies (Probe A and B) were more likely to enter
and remain with the vesicles, since they are more likely to bind to
exposed VGLUT-2s and be co-transported into the lumen upon
vesicular form ation. Though still possible through passive diffusion,
non-VGLUT-2 probes (C and D) are less likely to be actively taken into
vesicles.

Once inside the vesicular lumen, the probe's fate is co-determined with
that of the vesicle. Excluding degradation, three proposed, post-uptake
vesicular mechanisms may affect probe efficacy. Vesicles may exist in
a transient kiss-and-run cycle, a short-term recycling pool, or a long
term reserve pool (Ceccarelii et al., 1973; Heuser and Reese, 1973;
Wu et al., 2007). Although the molecular processes underlying the
kiss-and-run recycling mechanism are still unclear, this pathway is too
transient for any appreciable probe vesicular entry; it may even return
probes into the synaptic cleft. It is therefore unlikely to be a starting
point fo r probes that reach the soma. Vesicles tha t follow the short
term recycling pool or long-term reserve pool pathway exist long
enough to be reasonable probe entry points. Probes th at display PEI
conjugates (Probe A and C) take advantage of the "proton sponge
effect", which facilitates th e ir escape into the cytosol. Non-PEI probes
(Probe B and D) are less likely to exit intact vesicles, since the
vesicular plasma membrane presents a significant barrier. Due to
physical obstruction, non-PEI probes can presumably exit into the
cytosol, in appreciable amounts, only when the vesicle itself and
integral membrane proteins, are lysed and degraded by the cellular
machinery.

As a consequence of the relative absence of lysosomes within the
presynaptic term inal, integral vesicular membrane proteins are
retrogradely transported to the soma, where they are destroyed by
lysosomes (Li and Dahlstrom, 1997; Tsukita and Ishikawa, 1980). In
this sense, we can explain the near sim ilarities in Probe B and C's
efficacy rates in the following way: while probes with the VGLUT-2antibody are more likely to remain within the vesicles, and therefore
be present in larger numbers post-form ation, only a small percentage
escape passively into the cytosol and reach the soma, presumably
through vesicle degradation. For PEI-conjugated probes, the reverse is
true: while relatively fewer of them passively remain in the vesicle
post-form ation, those th a t do are more likely to actively escape into
the cytosol, through vesicle osmolysis, and transport to the soma.
Furthermore, the absence of either the VGLUT-2 or VGAT antibody
renders these particular probes to enter neurons nonspecificaily, with
regards to phenotype. While it is clear that possessing either conjugate
may be sufficient to reach the soma, efficacy rates are significantly
much higher and more specific, when both are concurrently present, to
take advantage of as many vesicular pathways as possible.

Although conjugate type plays a significant role, overall size may also
influence probe efficacy. While adding the appropriate conjugates

facilitates probe specificity, it also adds to the probe complex's size.
The larger the size, the more likely steric effects (such as blockage or
entanglem ent) may influence efficacy. We are likely seeing this effect
when comparing the relatively larger Probe C complex with th a t of
Probe D (Table 2). Despite Probe D's lack of any facilitative
conjugates, tissue injected with this "naked" probe shows a
comparable efficacy rate to its deconjugated counterpart.
Concurrently, we also observe th at merely increasing the probe shell
size, as in the case of Probe DX, is sufficient to diminish efficacy rates.
When coupled with its biocom patibility, the unconjugated, 5-nm
probes take advantage of various mechanisms to enter neurons, which
th e ir conjugated counterparts cannot, such as occasionally passing
interstitiaily through the plasma membrane (Verma et al., 2008). From
this, we observe that the trad e-o ff in specificity is m obility.

As for the GABAergic probes, it seems unusual that Probe Z labels POA
neurons at a significantly lower efficacy rate, especially when the
GABAergic phenotype comprises the m ajority of hypothalamic neurons
(~ 6 0 % ). Several m itigating factors, however, may explain the lower
than expected rate.

From a chemical standpoint, VGAT's binding potential to its
endogenous cargo (GABA), is different from VGLUT-2's interaction with
its endogenous ligand (glutam ate). I f the principle of a "m olecular
velcro" does apply to the facilitated vesicular entry of these probes,
then it is reasonable to assume th at the differential binding kinetics
between these two transporters may affect the binding interactions
with th e ir respective probes. This, in turn, alters the likelihood of
vesicular uptake and therefore, somatic labeling. Furthermore, at
physiological tem peratures (~ 36°C ), glutamate is endocytosed at
faster rates and in larger vesicular com partments (approxim ately 4-5
fold; Roskoski, 1978). These differences may be related to glutam ate's
general metabolic role in neuronal cells, as opposed to GABA's more
specialized, neurotransm itter capacity.

5. CONCLUSIONS AND FUTURE DIRECTIO NS

Several validation studies, to fu rth e r assess the technique's viability,
are currently under way. For example, direct histochemical techniques
are being applied to verify and establish the accuracy of each probe's
phenotypic-tagging capabilities. In another study, we are attem pting
to patch clamp from live, labeled neurons and then ascertain
attenuations (or enhancements) from recorded electrical signals, if

any. Preliminary indications from patch clamp attem pts, suggest that
labeled neurons do remain viable and are still capable of displaying
firing patterns.

The possibilities fo r future studies are numerous. As the body of
nanobiotechnological knowledge grows, m iniaturization technologies
mature, and novel materials are introduced, future refinem ent of this
technique is inevitable. This m ethodology has already demonstrated its
wide applicability, by allowing conjugation of glutam atergic and
GABAergic antibodies, and thereby targeting the two most abundant
neurotransm itter systems in the central nervous system. Countless
conjugate perm utations could allow fo r specific visualization,
customized characterization, connectivity assessment, and
electrophysiological recording of hypothalamic cells and various other
neuronal populations (e.g. cortical, hippocampal, interneuronal, etc.)
within the brain and its periphery.
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